How Good is EPS at Predicting the Future After TAVR?

Permanent pacemaker (PPM) implantation continues to be a significant complication of transcatheter aortic valve replacement (TAVR), occurring in approximately 12% of patients [1]. While device enhancements of new TAVR valves, better patient selection and operator experience have led to a decrease in paravalvular regurgitation, vascular injury, stroke, and new dialysis requirement, pacemaker implantation appears to be the only complication that is increasing in frequency [1]. As TAVR expands to patients with lower risk, the long-term consequences of pacemaker implantation will likely be amplified.
Source: Cardiovascular Revascularization Medicine - Category: Cardiology Authors: Source Type: research